The Haemorrhoid Centre Limited - Accounts to registrar (filleted) - small 18.2

The Haemorrhoid Centre Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.2.0.376 05162136 Board of Directors 1.7.20 30.6.21 30.6.21 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure051621362020-06-30051621362021-06-30051621362020-07-012021-06-30051621362019-06-30051621362019-07-012020-06-30051621362020-06-3005162136ns16:EnglandWales2020-07-012021-06-3005162136ns15:PoundSterling2020-07-012021-06-3005162136ns11:Director12020-07-012021-06-3005162136ns11:PrivateLimitedCompanyLtd2020-07-012021-06-3005162136ns11:SmallEntities2020-07-012021-06-3005162136ns11:AuditExempt-NoAccountantsReport2020-07-012021-06-3005162136ns11:SmallCompaniesRegimeForDirectorsReport2020-07-012021-06-3005162136ns11:SmallCompaniesRegimeForAccounts2020-07-012021-06-3005162136ns11:FullAccounts2020-07-012021-06-3005162136ns11:Director22020-07-012021-06-3005162136ns11:RegisteredOffice2020-07-012021-06-3005162136ns6:CurrentFinancialInstruments2021-06-3005162136ns6:CurrentFinancialInstruments2020-06-3005162136ns6:ShareCapital2021-06-3005162136ns6:ShareCapital2020-06-3005162136ns6:RetainedEarningsAccumulatedLosses2021-06-3005162136ns6:RetainedEarningsAccumulatedLosses2020-06-3005162136ns6:CurrentFinancialInstrumentsns6:WithinOneYear2021-06-3005162136ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-06-30
REGISTERED NUMBER: 05162136 (England and Wales)












FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2021

FOR

THE HAEMORRHOID CENTRE LIMITED

THE HAEMORRHOID CENTRE LIMITED (REGISTERED NUMBER: 05162136)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 30 June 2021










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


THE HAEMORRHOID CENTRE LIMITED

COMPANY INFORMATION
for the year ended 30 June 2021







DIRECTORS: C R Reynolds
L J Reynolds





REGISTERED OFFICE: Unit B3 Walker Business Park
Threemilestone
Truro
Cornwall
TR4 9FB





REGISTERED NUMBER: 05162136 (England and Wales)





ACCOUNTANTS: Magma Audit LLP
Unit 2
Charnwood Edge Business Park
Syston Road
Leicester
LE7 4UZ

THE HAEMORRHOID CENTRE LIMITED (REGISTERED NUMBER: 05162136)

BALANCE SHEET
30 June 2021

2021 2020
Notes £    £   
FIXED ASSETS
Investments 4 41,161 -
Investment property 5 24,535 24,535
65,696 24,535

CURRENT ASSETS
Debtors 6 39,803 -
Cash at bank 125,001 141,708
164,804 141,708
CREDITORS
Amounts falling due within one year 7 (19,526 ) (13,120 )
NET CURRENT ASSETS 145,278 128,588
TOTAL ASSETS LESS CURRENT
LIABILITIES

210,974

153,123

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 210,973 153,122
210,974 153,123

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 September 2021 and were signed on its behalf by:





C R Reynolds - Director


THE HAEMORRHOID CENTRE LIMITED (REGISTERED NUMBER: 05162136)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 30 June 2021


1. STATUTORY INFORMATION

The Haemorrhoid Centre Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
- the amount of revenue can be measured reliably;
- it is probable that the company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the cost incurred and the costs to complete the contract can be measured reliably

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

The investment property has been valued at open market value at the year end by the director.

Financial instruments
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Taxation
The tax expense for the year comprises current and deferred tax.

Tax is recognised in profit or loss except that a change attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that:

- The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered
against the reversal of deferred tax liabilities or other future taxable profits; and
- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Both current and deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

THE HAEMORRHOID CENTRE LIMITED (REGISTERED NUMBER: 05162136)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 June 2021


2. ACCOUNTING POLICIES - continued

Debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related
parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.

Operating leases
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Leases that do not transfer all the risks and rewards of ownership are classified as operating leases. Payments under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalents
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2020 - 1 ) .

4. FIXED ASSET INVESTMENTS

Investments (neither listed nor unlisted) were as follows:
2021 2020
£    £   
Additions 44,650 -
Revaluation (3,489 ) -
41,161 -

THE HAEMORRHOID CENTRE LIMITED (REGISTERED NUMBER: 05162136)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 30 June 2021


5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 July 2020
and 30 June 2021 24,535
NET BOOK VALUE
At 30 June 2021 24,535
At 30 June 2020 24,535

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Other debtors 39,803 -

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade creditors 34 -
Corporation tax 13,991 8,420
VAT 4,645 2,360
Other creditors - 1,484
Accruals and deferred income 856 856
19,526 13,120